InvestorsHub Logo
Followers 0
Posts 142
Boards Moderated 0
Alias Born 05/20/2016

Re: None

Monday, 06/13/2016 2:11:51 PM

Monday, June 13, 2016 2:11:51 PM

Post# of 233151
From Seeking Alpha:

tonecee
Comments (6) |+ Follow
How will Cytodyn's Pro 140 (if approved by the FDA)once a week injection for the treatment of HIV affect Gilead HIV market share?
13 Jun 2016, 11:06 AM

DoctoRx , Contributor
Comments (6895) |+ Follow |Send Message
Author’s reply »
Tonecee, I don't know. It's mostly in Phase 2. With a market cap of $0.14 B ($140 MM), I'm sure that GILD or ViiV would have bought it or partnered with it if they believed there was some reasonable commercial potential there. Dr. B did address this topic in one of his recent comments, saying that GILD is looking into a long-acting injectable, but that he didn't think there was a lot of commercial potential there.
NEW | 13 Jun 2016, 11:20 AM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News